OR WAIT null SECS
October 02, 2013
Industry experts discuss the importance of characterization studies during biosimilars development and related analytical methods.
September 25, 2013
Pfizer advances its pipeline of antibody-based therapies using a host cell line that combines engineered glycosylation technology and enhanced gene-expression.
September 11, 2013
Novartis? half-billion dollar investment in a new biologics production plant in Singapore represents a strategic commitment to its growing biologics portfolio.
September 06, 2013
Following passage in the California Assembly, the California State Senate passes legislation to specify requirements for dispensing biosimilars.
September 02, 2013
Industry experts discuss the requirements and challenges involved in getting a biosimilar product from bench to launch.
August 28, 2013
Conventional cell-imaging systems that provide high quality data can be expensive and complex to use. New systems from Biotek Instruments are designed to overcome these issues.
Installation of a quaternary chiral center with high enantioselectivity using memory of chirality enabled the six-step synthesis of the desired active compound.
Extensive adoption of single-use technologies and unidirectional flow reduces cross-contamination risk in the company?s new biomanufacturing facility.
Conventional cell-imaging systems that provide high quality data can be very expensive and complex to use. New systems from Biotek Instruments are designed to overcome these issues.
August 02, 2013
Extensive comparability testing is required to ensure that biosimilars have comparable profiles to their reference products.